Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

NCT00618618 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate or Severe Submental Fullness

Interventions

DRUG: Deoxycholic Acid Injection
DRUG: Placebo

Sponsor

Kythera Biopharmaceuticals